Bristol Myers Rallies; Adobe Slips; Salesforce Up After BofA AI Upgrade


Bloomberg Stock Movers: BMY rises on promising late-stage drug data; ADBE falls after Wells Fargo downgrade; CRM gains as BofA upgrades to Buy citing AI tailwinds.

Editorial companion

What stands out

Bloomberg highlights short, specific reasons these three stocks moved today: Bristol Myers rose after late-stage drug data suggested efficacy in two hard-to-treat conditions, Adobe fell after Wells Fargo cut its rating, and Salesforce climbed after Bank of America raised its recommendation citing AI adoption. The clip matters because it ties single events, trial readouts, an analyst downgrade, and an AI-driven upgrade, to the price action that traders saw, showing how concentrated news can reshape sentiment in a single session.